India proposes price regulation for patented drugs

02/27/2013 | Economic Times (India), The

A government panel in India has recommended that prices for expensive drugs to treat critical diseases like HIV, cancer and hepatitis be based on the nation's per capita income, which could substantially reduce their costs and make them more affordable for patients. Some in the industry warn, however, that the regulations could backfire and instead prevent companies from offering new drugs in India.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA